Picture Demy-Colton BioFuture 2023 NYC Hand 650x100px
Organisation › Details

Intrinsic Bioprobes Inc. (IBI)

Intrinsic Bioprobes Inc. is a privately held Biotechnology Company focused on the development and application of clinical and diagnostic assays and platforms for rapid and sensitive protein biomarker analysis. The company's proprietary technologies consist of Mass Spectrometric Immunoassay (MSIA), a high-performance approach for the selective isolation of proteins from complex biological matrices, and Bioreactive Mass Spectrometer Probes (BRP), devices for rapid, sensitive and accurate protein characterization. These root technologies are incorporated into the MASSAY System, a high throughput mass spectrometry platform for rapid protein biomarker analysis. *


Period Start 1996-01-01 established
  Group Thermo Fisher (Group)
Products Industry proteomics
  Industry 2 MSIA technology (mass spectrometric immunoassay)
Person Person Nedelkov, Dobrin (Intrinsic Bioprobes 201007 CEO)
Region Region Tempe, AZ
  Country United States (USA)
  Street 2155 E. Conference Drive
Suite 2155
  City 85284 Tempe, AZ
  Tel +1-480-804-1778
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for »About Section«: 
Record changed: 2023-07-10


Picture EBD Group ChinaBio Partnering Forum 2023 Shanghai 650x200px

More documents for Thermo Fisher (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Demy-Colton BioFuture 2023 NYC View 650x300px

» top